Member Info for TrekMadone

Broke my sell down into 5 trades.

First 3 were executed for 21.09p don’t think the next two will be so lucky. Still waiting.

Hopefully enough left for a punt on that national tree surgeon!

Good luck all!

Trek

I was going to do my usual Friday sell but we had no power and no cellphone coverage!

In any event there were more important things to do in looking out for our neighbours.

So here’s the plan.

I am going to take out what’s left and invest in tree surgeons!

Hope all investors only lost what they can afford.

Good luck with your investments.

Trek

News at last but not sure why 12 months for first gas. Seems long time.

Usual caveats

Trek

I like the simple regular updates from this company. Without the lab results I doubt this will move the market.

Note the thickness and depth of these drills together with a potential JORC update. 4m cores to be broken back and previous results as a reminder.

There is no certainty but another good set of numbers and this could rerate to ATH’s providing a nice cushion for those tucking away stock now.

I think end of Feb for results is earlier than the market expected and so is the sulphide thickness.

Usual caveats

Trek

Hi gotabe,

Yes will do. I noticed that on the HL site there is a tick for ISA!

Trek

Some flaky journalism from yahoo finance. I mean they are promoting divi stocks and get the divi wrong! Also they omit the pe is impacted by debt repayments and that each project has individual finance. But hey, they still like the theme!

‘ ContourGlobal (7.7% dividend yield)

Power generator ContourGlobal (LSE: GLO) has the wind in its sails at the moment. In December it upgraded its profits guidance for 2021 thanks to better-than-expected performance from one of its Spanish natural gas plants. I don’t think this dividend stock’s just a great buy for today, though. I reckon it’s a good way to make money from soaring energy consumption around the globe.

ContourGlobal builds and operates power stations across Europe, Africa and Latin America. Demand for its services should hopefully grow as population levels increase and economic output in emerging markets takes off. I also like this particular energy producer because of its growing focus on renewable energy. This could help its share price rise over the long term as the theme of responsible investing takes off.

But I’m aware that today ContourGlobal trades on a high forward P/E ratio of around 29 times. A premium share price always leaves a company in danger of sinking if earnings forecasts start to look a bit flaky. A project delay is one danger that could send ContourGlobal’s share price reversing sharply.’

https://uk.finance.yahoo.com/news/6-dividend-yields-5-best-084607041.html

Trek

Hi Bankrupty,

Fx was the reason I didn’t buy. Converting to real to usd is expensive. But I think it may be baked in. On sidelines btw.

Usual caveats

Trek

Why is it that when you find a couple of good goldies you buy the others ones!

Yamaha been on my buy list for ages. I kind knew it would move quickly on the POG but chose more risky plays. Wish I have followed my nose into here, unless those other plays come off of course!

Nevertheless well done to holders here I see £4 very quickly given their production profile.

Usual caveats

Trek

Been some excellent balanced posts here of late.

Likewise I am in the camp of the need to deliver Coho. Share prices in particular for low volume small caps are sentiment driven. Sentiment is driven by news or delayed news.

Look back through the RNS’s and the Proactive vids and you can see how our colours were nailed to Coho. I for one let out a huge sigh of relief when plucking my golf clubs out of the back of the car and that one landed. It derisked my hole pf not just the model! It set TXP up as a rising star. Then Casca arrived and euphoria set in! Casca deep, wall of cash! Then Chinook - we get it, even the market had started to come around to our idea of ‘recalibrating’ the drill.

Now Coho seems to be relegated to an also ran. More Delays. The change in narrative has spooked some of those later investors that bought the derisked story. The jury is now out on the CPR in terms of being a SP catalyst, mine to.

I really feel the pain of those that are underwater here. Easy for some of us that can see through this news hiatus because we are well up and can appreciate how the ops should change soon.

Sentiment is a fickle beast. It can be changed quickly with just one good update. Will the 14th March be enough. It doesn’t look like it. Sp is hardly rising on anticipation. For sure the CPR is an essential regulatory ingredient but we need more. News from the drill bit, production and an operational headliner will quickly change sentiment.

ATM next years ISA bargain is looking nailed on but for the sake of the whole project and for those looking at paper losses I would much rather be paying more!

Get a wiggle on Paul! Please.

Usual caveats

Trek

Had a look at these, went to buy a few but not eligible for ISA! Just in case someone else misses that.

Trek

Spain earlyCDT lung approval. Expecting NHS contracts next.

Update at interims on the last ‘non payment’ collection and further revenue growth and this could be off.

I am as frustrated here as the rest. Progress is being made on all fronts yet the SP languishes. For perspective though it is sector wide and tracks back to interest rate rises imo. Only larger cap divi payers are up. But even some of those have fallen back. Small caps having a tough time.

Some sector M&A must be due on these valuations

Usual caveats

Trek

Over hey?…..

Not according to the BBC and what modern government is going to be negligently unprepared for the next VoC….

“ 3. Hong Kong's hospitals overwhelmed amid spike in cases
Hong Kong's healthcare system has been overwhelmed by a huge surge in Covid cases, with infected patients being treated outside crowded hospitals. It comes as a record 4,285 new cases were reported on Wednesday. The government is struggling to contain a fifth wave of infections. Officials have ruled out a city-wide lockdown but Chinese President Xi Jinping urged local leaders to take "all necessary measures" to control the outbreak.”

No link via app..

Usual caveats

Trek

Hi Lloyd,

I took a read across from that as well. Shows they are stretched there with the pandemic and process.

Usual caveats

Trek

1.58 v1.6339, 100k on ii.

MM just working the spread as usual.

Walking the dog!

Trek

1.55 v 1.60 on ii.

Trek

I just don’t get why they, HEMO, write RNS’s like this. There are so many positives in this change, costs, end to end speed etc it can be worded to convey the same news without kicking the door open for traders. Oh the irony!

And as for ‘an encouraging manner’. Wtf does that mean!

Gosh if only I had delayed yesterday’s top up!

Thankfully have some powder dry to grab a few more if the SP ‘distorts’.

Futures up today; after a good market day yesterday there is often a small cap catch up. Will take all the help we can get as atm doing nothing is my preferred option!

Usual caveats

Trek

Pretty disappointing imo. I think that plus500 results have spooked.

Usual caveats

Trek

Don’t think it’s a relevant question at this juncture. Just a curved ball post.

Successful read out….. cash won’t be an issue because….

# SP higher so any placing should be well above ATH’s
# Government investment to get SNG on the shelf, not just for now but for future VoC’s like ‘Deltacron’. Funding could be part of a supply deal.
# company could be bought outright. It’s then someone else’s issue.

If readout is not successful. For sure money could be needed for further clinical trials. COPD whatever but SP will be much lower and in most peoples bottom drawers.

So you see funding isn’t the right question to ask. Accepting all the evidence thus far points to a positive outcome. The question one should ask is if the read out isn’t successful have I overexposed my wealth here.

For sure to make a life changing difference one has to have a few bob invested, if that’s what you want. But can you survive without it. That’s the question, well even that should have been answered by now!

Not the companies financial standing at this point in time. So close and all that.

Usual caveats

Trek

Would do same again Hemo, hindsight and all that but I prefer to have cash options on the side during hi vix.

Some other stocks I bought back much cheaper at the bell today. Just paid more for this one but I still have good risk exposure here to any upside.

I change my position according to data. E.g lots of folk chasing oilies atm. Todays Russian troop pull back is either a double bluff or good news. Oil futures though were in backwardation before the news tells me POO likely near the top. A few now stuck with buys made yesterday. That was the sell imo.

Pharma stock sentiment is at an all time low. Sector sentiment linked to interest rates, covid and consequential delays in ops etc. not so long ago Pharma was viewed as a defensive. That only seems to apply to big pharma divi players now but even there covid has delayed some revenue.

Sector could do with some M&A as valuations are so cheap even for those stocks with patents and on clinical trials.

Makes it a contrarian buy at this level imo only if you can sit through it or trade it.

I try a hybrid, hold some trade some as my trading isn’t that brilliant but getting much better as I focus on fewer stocks now. Made 43 trades over yesterday and today. Made some profits. Got some better averages and trimmed some losses

Golden rule is only buy what you don’t mind getting stuck with. Hence more than happy to work this one.

Good luck with your investments

Trek

POG, looks like on a TA basis if it doesn’t break up it breaks back down. My own view is we are on an Elliot wave back up. But wtfdik!

“ Recent price behaviour and the failure of gold to stay above 1.837 gives rise to concern. To recapture the bullish outlook, 1.877 has to be taken out, else it opens the door for a longer term corrective structure down towards 1.530.

1.877 (1.880) is now the structural pivot where the outlook changes from bearish to bullish and longer-term mathematical targets change from 1.530 down to 2.075 and 2.310 and maybe even 2.550 up. Volume patterns support the bullish outlook as do the fundamentals, but the recent failures are of concern. Because gold has failed to follow through on the last two upside breakouts, the door is still open for a continued correction, that started in August 2020, down towards 1.530, but the fundamental outlook is still strong.

Should the bullish outlook be allowed to get foothold, the sky will not be the limit, but price targets up towards 2,300-2.500 can be argued for; this will need fine tuning down (or should we say up) the road, when we get a bullish structure in place above the 1,877 USD/Oz pivot”

https://www.thearmchairtrader.com/gold-trading-precious-metal-technical/

Trek